31097255 32292544 32519686 31204543 35328340 29405541 27211244 32397127 28475149 35005956 33923369 28514117 27226199 31451830 31935054 29335692 31351913 33387547 31358273 29087712 33002682 33016117 - Search Results

Year	Number of Results
2016	1
2017	4
2018	2
2019	4
2020	8
2021	2
2022	2

1

Cyanobacterial bioactive metabolites-A review of their chemistry and biology.

Huang IS, Zimba PV. Huang IS, et al. Harmful Algae. 2019 Mar;83:42-94. doi: 10.1016/j.hal.2018.11.008. Epub 2019 Feb 22. Harmful Algae. 2019. PMID: 31097255 Review.

2

Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.

Luo D, Luesch H. Luo D, et al. ACS Med Chem Lett. 2020 Mar 4;11(4):419-425. doi: 10.1021/acsmedchemlett.9b00473. eCollection 2020 Apr 9. ACS Med Chem Lett. 2020. PMID: 32292544 Free PMC article.

3

Targeting eukaryotic proteases for natural products-based drug development.

Al-Awadhi FH, Luesch H. Al-Awadhi FH, et al. Nat Prod Rep. 2020 Jun 24;37(6):827-860. doi: 10.1039/c9np00060g. Nat Prod Rep. 2020. PMID: 32519686 Free PMC article. Review.

4

A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications.

Crocetti L, Quinn MT, Schepetkin IA, Giovannoni MP. Crocetti L, et al. Expert Opin Ther Pat. 2019 Jul;29(7):555-578. doi: 10.1080/13543776.2019.1630379. Epub 2019 Jun 16. Expert Opin Ther Pat. 2019. PMID: 31204543 Review.

5

Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview.

Marinaccio L, Stefanucci A, Scioli G, Della Valle A, Zengin G, Cichelli A, Mollica A. Marinaccio L, et al. Int J Mol Sci. 2022 Mar 8;23(6):2924. doi: 10.3390/ijms23062924. Int J Mol Sci. 2022. PMID: 35328340 Free PMC article. Review.

6

Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.

Al-Awadhi FH, Paul VJ, Luesch H. Al-Awadhi FH, et al. Chembiochem. 2018 Apr 16;19(8):815-825. doi: 10.1002/cbic.201700627. Epub 2018 Mar 23. Chembiochem. 2018. PMID: 29405541 Free PMC article.

7

Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium.

Al-Awadhi FH, Ratnayake R, Paul VJ, Luesch H. Al-Awadhi FH, et al. Bioorg Med Chem. 2016 Aug 1;24(15):3276-82. doi: 10.1016/j.bmc.2016.04.062. Epub 2016 Apr 30. Bioorg Med Chem. 2016. PMID: 27211244 Free PMC article.

8

Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Tan LT, Phyo MY. Tan LT, et al. Molecules. 2020 May 8;25(9):2197. doi: 10.3390/molecules25092197. Molecules. 2020. PMID: 32397127 Free PMC article. Review.

9

New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Mi Y, Zhang J, He S, Yan X. Mi Y, et al. Mar Drugs. 2017 May 5;15(5):132. doi: 10.3390/md15050132. Mar Drugs. 2017. PMID: 28475149 Free PMC article. Review.

10

Total Synthesis of Pseudouridimycin.

Wang XK, Jia YM, Li YX, Yu CY. Wang XK, et al. Org Lett. 2022 Jan 21;24(2):511-515. doi: 10.1021/acs.orglett.1c03914. Epub 2022 Jan 10. Org Lett. 2022. PMID: 35005956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results